SLN

Silence Therapeutics PLC

Price

$12.34

return (12m)

152.25%

p/e

-31.46

p/bv

49.03

DIVIDEND YIELD

0.00%

SLN price

Silence Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SLN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.76%

3 months

77.99%

1 year

152.25%

2 years

-32.63%

5 years

-45.64%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SLN

Valuation

P/E

-31.46

Sector -3.50

Industry -3.50

P/BV

49.03

Sector 2.02

Industry 2.02

P/Revenue (PSR)

3,066.92

Sector 2.01

Industry 2.01

EV/EBITDA

-131.87

Sector -214.99

Industry -214.99

EV/EBIT

-130.84

Sector -47.59

Industry -47.59

P/EBITDA

-27.81

Sector -21.41

Industry -21.41

P/EBIT

-27.61

Sector -28.65

Industry -28.65

P/Total Assets

17.73

Sector 1.19

Industry 1.19

P/Net Current Assets

71.61

Sector -11.97

Industry -11.97

P/Working Capital

23.12

Sector -167.95

Industry -167.95

EPS

-0.42

Sector -1.81

Industry -1.81

BVPS

0.27

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

85.85%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-155.84%

Sector -56.04%

Industry -56.04%

ROA

-56.34%

Sector -60.31%

Industry -60.31%

ROIC

-196.58%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

7.42

Sector 2.89

Industry 2.89

Net Debt / EBITDA

5.24

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

5.20

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.87

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.36

Sector 0.46

Industry 0.46

Liabilities/Assets

0.64

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-48.50%

Sector -

Industry -

5Y Earnings CAGR

2.14%

Sector -

Industry -

Fundamentals SLN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SLN Silence Therapeutics PLC	$12.34	146.21%	0.00%	-31.46	49.03	-155.84%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.09%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	42.33%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.88%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SLN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Silence Therapeutics

Silence Therapeutics PLC

Average Investor10 user rating

4.0 (0 people)

United States

32 years

Founded: 1994

2020

Time since IPO - 6 years

74

Employees

Silence Therapeutics PLC (United States) is listed on the Nasdaq and has a market capitalization of $1.89 billion, with shareholders equity totaling $38.47 million.

The company employs approximately 74 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Silence Therapeutics PLC reported $615.00 Thousand in revenue, generating net income of $-59.95 million.

Key financial metrics include a P/E ratio of -31.46, a price-to-book (P/B) ratio of 49.03, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SLN.

Market cap

$1.89 billion

Net worth

$38.47 million

$38,471,000.00

Assets

$106.41 million

$106,412,000.00

Total Shares Outstanding

141.71 million

141,709,000

Average Daily Trading Volume

$1.12 million

$1,118,118.00

Sector

Health Care

Industry

Biotechnology

SLN

SLN revenue and profits

Financial Results SLN

DRAG THE FRAME TO SEE MORE DATA

SLN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,90% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$224.45 51,94% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 86,25% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,90% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$224.45 51,94% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 86,25% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Silence Therapeutics (SLN) today?

A cotação de Silence Therapeutics (SLN) hoje está em US$ 12.34, com uma variação de 152.25% em relação ao último ano. A cotação de Silence Therapeutics (SLN) iniciou o ano negociando na casa dos US$ 6.08 e hoje está em US$ 12.34. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Silence Therapeutics (SLN) e dados de ações do Ibovespa e mercados internacionais.

Quando Silence Therapeutics (SLN) paga dividendos?

Silence Therapeutics (SLN) não distribuiu dividendos no último ano.

Is Silence Therapeutics (SLN) a good investment?

Atualmente, Silence Therapeutics (SLN) está cotada a US$ 12.34, com um P/L de -31.46, representando um desvio de -1,423% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 152.25 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 152.25%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Silence Therapeutics (SLN) stock?

Investir em ações de Silence Therapeutics (SLN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Silence Therapeutics (SLN) yield today?

A rentabilidade de Silence Therapeutics (SLN) foi de -6.76% no último mês, 152.25% no último ano e -45.64% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Silence Therapeutics (SLN) hoje, o investimento total seria de US$ 1,233.50, com base na cotação atual de US$ 12.34.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 3,111.50
Em 5 anos: US$ 670.53
Em 10 anos: US$ 1,233.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SLN

Silence Therapeutics PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SLN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SLN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Silence Therapeutics

Silence Therapeutics PLC

United States

32 years

2020

74

PROFIT X PRICE SLN

Financial Results SLN

SLN cash flow

Asset, Revenue and Profit Growth - SLN

SLN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions